Latest Industry Insights

Exposure to high levels of PFAS can be damaging to human health, and is associated with complications in reproduction, immune responses and some types of cancer. These issues, coupled with growing concerns about the impact of PFAS on the environment, mean that the detection and identification of PFAS has become a top priority for environmental testing laboratories worldwide.

In this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.

As a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.

We recently spoke with Meredith Carpenter, Director of Assay Research and Development for Arc Bio, to learn more about the capabilities of metagenomic next-generation sequencing in identifying infections.

Trisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.

In this week's instalment of "Technology Networks Explores the CRISPR Revolution", we're focusing on the technical elements of CRISPR technology. Helping us to answer key questions in this space is Dr Amy Butler, President of the Biosciences Division at Thermo Fisher Scientific.

From the ground, to space, technologies are developed and deployed to help us protect and better understand the world around us. We hear how one such solution is aiding the mission to measure the changing heights of glaciers on Earth as the planet warms.

To keep pace with progress in the biopharmaceutical industry, other technologies have also needed to advance. Mass spectrometry and liquid chromatography have similarly gained ground, innovating rapidly to meet the challenges and opportunities that this new type of therapeutic brings.

Recently, we interviewed George Karlin-Neumann, Clinical Director, Digital Biology Group at Bio-Rad Laboratories to learn more about ddPCR and its applications.